WESTFORD, Mass., May 30 /PRNewswire-FirstCall/ -- Cynosure, Inc. , a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the Sixth Annual Needham Biotechnology & Medical Technology Conference on Wednesday, June 13, 2007 at 2:00 p.m. ET from The New York Palace Hotel.
President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker will discuss Cynosure’s business outlook, growth strategy and recent financial results. Investors interested in listening to the live webcast of this presentation should log on to the “Investor Relations” section of Cynosure’s website, www.cynosure.com, and click on the link labeled “Events.” The presentation will be archived on the company’s website.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure’s products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.
For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.
Contact Scott Solomon Vice President Sharon Merrill Associates, Inc. 617-542-5300 cyno@investorrelations.com
Cynosure, Inc.
CONTACT: Scott Solomon, Vice President of Sharon Merrill Associates, Inc.,+1-617-542-5300, cyno@investorrelations.com, for Cynosure, Inc.
Web site: http://www.cynosure.com/
